Literature DB >> 23647759

Implementation and initial clinical experience of offline PET/CT-based verification of scanned carbon ion treatment.

Julia Bauer1, Daniel Unholtz, Florian Sommerer, Christopher Kurz, Thomas Haberer, Klaus Herfarth, Thomas Welzel, Stephanie E Combs, Jürgen Debus, Katia Parodi.   

Abstract

BACKGROUND AND
PURPOSE: We report on the implementation of offline PET/CT-based treatment verification at the Heidelberg Ion Beam Therapy Centre (HIT) and present first clinical cases for post-activation measurements after scanned carbon ion irradiation. Key ingredient of this in-vivo treatment verification is the comparison of irradiation-induced patient activation measured by a PET scanner with a prediction simulated by means of Monte Carlo techniques.
MATERIAL AND METHODS: At HIT, a commercial full-ring PET/CT scanner has been installed in close vicinity to the treatment rooms. After selected irradiation fractions, the patient either walks to the scanner for acquisition of the activation data or is transported using a shuttle system. The expected activity distribution is obtained from the production of β(+)-active isotopes simulated by the FLUKA code on the basis of the patient-specific treatment plan, post-processed considering the time course of the respective treatment fraction, the estimated biological washout of the induced activity and a simplified model of the imaging process.
RESULTS: We present four patients with different indications of head, head/neck, liver and pelvic tumours. A clear correlation between the measured PET signal and the simulated activity pattern is observed for all patients, thus supporting a proper treatment delivery. In the case of a pelvic tumour patient it was possible to detect minor treatment delivery inaccuracies.
CONCLUSIONS: The initial clinical experience proves the feasibility of the implemented strategy for offline confirmation of scanned carbon ion irradiation and therefore constitutes a first step towards a comprehensive PET/CT-based treatment verification in the clinical routine at HIT.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23647759     DOI: 10.1016/j.radonc.2013.02.018

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  19 in total

1.  Initial development of goCMC: a GPU-oriented fast cross-platform Monte Carlo engine for carbon ion therapy.

Authors:  Nan Qin; Marco Pinto; Zhen Tian; Georgios Dedes; Arnold Pompos; Steve B Jiang; Katia Parodi; Xun Jia
Journal:  Phys Med Biol       Date:  2017-01-31       Impact factor: 3.609

Review 2.  Monte Carlo Simulations of Particle Interactions with Tissue in Carbon Ion Therapy.

Authors:  George Dedes; Katia Parodi
Journal:  Int J Part Ther       Date:  2016-02-09

Review 3.  In vivo range verification in particle therapy.

Authors:  Katia Parodi; Jerimy C Polf
Journal:  Med Phys       Date:  2018-11       Impact factor: 4.071

Review 4.  Carbon ion radiotherapy in the treatment of gliomas: a review.

Authors:  Timothy D Malouff; Jennifer L Peterson; Anita Mahajan; Daniel M Trifiletti
Journal:  J Neurooncol       Date:  2019-09-30       Impact factor: 4.130

5.  Visualisation of Range Shortening in Carbon Ion Beams and Washout of Positron Emitter: First-in-Human Report.

Authors:  Shintaro Shiba; Makoto Sakai; Masahiko Okamoto; Tatsuya Ohno
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

6.  Preclinical investigations towards the first spacer gel application in prostate cancer treatment during particle therapy at HIT.

Authors:  Antoni Ruciński; Julia Bauer; Patrick Campbell; Stephan Brons; Daniel Unholtz; Gregor Habl; Klaus Herfarth; Jürgen Debus; Christoph Bert; Katia Parodi; Oliver Jäkel; Thomas Haberer
Journal:  Radiat Oncol       Date:  2013-06-06       Impact factor: 3.481

7.  Monitoring of patients treated with particle therapy using positron-emission-tomography (PET): the MIRANDA study.

Authors:  Stephanie E Combs; Julia Bauer; Daniel Unholtz; Christopher Kurz; Thomas Welzel; Daniel Habermehl; Thomas Haberer; Jürgen Debus; Katia Parodi
Journal:  BMC Cancer       Date:  2012-04-03       Impact factor: 4.430

8.  Physics and biomedical challenges of cancer therapy with accelerated heavy ions.

Authors:  Marco Durante; Jürgen Debus; Jay S Loeffler
Journal:  Nat Rev Phys       Date:  2021-09-17

9.  Carbon-11 and Carbon-12 beam range verifications through prompt gamma and annihilation gamma measurements: Monte Carlo simulations.

Authors:  Ananta Raj Chalise; Yujie Chi; Youfang Lai; Yiping Shao; Mingwu Jin
Journal:  Biomed Phys Eng Express       Date:  2020-09-29

Review 10.  Range Verification Methods in Particle Therapy: Underlying Physics and Monte Carlo Modeling.

Authors:  Aafke Christine Kraan
Journal:  Front Oncol       Date:  2015-07-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.